About the Authors
- Håvard Midgard
-
* E-mail: havardmi@medisin.uio.no
Affiliations Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Jørgen G. Bramness
-
Affiliation Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway
- Svetlana Skurtveit
-
Affiliations Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway, Department of Pharmacoepidemiology, The Norwegian Institute of Public Health, Oslo, Norway
- John W. Haukeland
-
Affiliation Department of Gastroenterology, Oslo University Hospital, Oslo, Norway
- Olav Dalgard
-
Affiliations Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Competing Interests
HM has held sponsored lectures for Roche, Medivir, Gilead Sciences, MSD and AbbVie. OD has received research grants from Gilead Sciences and MSD, been a consultant for Medivir, AbbVie, MSD and Bristol Myers Squibb, and held sponsored lectures for Medivir, Bristol Myers Squibb, Abbvie and Gilead. JGB, SS and JWH have declared no competing interests. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: HM OD JGB. Data curation: HM SS. Formal analysis: HM OD JGB SS JWH. Funding acquisition: HM OD. Investigation: HM SS OD. Methodology: HM OD JGB SS JWH. Project administration: HM OD. Resources: HM SS OD. Software: HM SS. Supervision: OD. Validation: HM OD. Visualization: HM OD. Writing – original draft: HM OD. Writing – review & editing: HM OD JGB SS JWH.